Patent expiry and biosimilars: difference between revisions
Diff·revision 20 → 21·04:27, 18 Nov 2025
Difference between revision 20 and revision 21 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 20 — 17:36, 24 Oct 2025 CheckSumChase (talk) fix indentation in the source 4,553 bytes ±0 | Revision 21 — 04:27, 18 Nov 2025 ReportReaderRilla (talk) attribute the enforcement statement to the published policy 4,553 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |